康恩贝：腺苷钴胺胶囊拟中标第十一批全国药品集中采购

Core Viewpoint - The announcement indicates that the company's subsidiary, Hangzhou Kang En Bei Pharmaceutical Co., Ltd., has participated in the national organized bulk procurement of pharmaceuticals, with a favorable outcome for its product, adenosylcobalamin capsules [1] Group 1: Procurement Details - Hangzhou Kang En Bei's adenosylcobalamin capsules are proposed to be awarded a bid at a price of 3.81 yuan per box [1] - The proposed supply quantity for the provinces (regions) is 8.3224 million capsules, with supply locations including Sichuan, Hubei, and Ningxia [1] - The procurement cycle is set for 3 years, with a contractual agreed supply volume of 2.62 million capsules [1] Group 2: Impact on Company Performance - The successful bid is expected to facilitate rapid sales growth and market expansion for the product [1] - This development is anticipated to have a positive impact on the company's future operating performance [1]